|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0018270,
umls-concept:C0086418,
umls-concept:C0205146,
umls-concept:C0205217,
umls-concept:C0392756,
umls-concept:C0520484,
umls-concept:C0871261,
umls-concept:C1140680,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1801960,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-2-11
|
|
pubmed:abstractText |
Expression of aminopeptidase N/CD13 can be detected in several solid tumor types. Thus far, the role of CD13 in ovarian cancer has not been studied. We have investigated the expression pattern and biological function of CD13 in ovarian cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aminopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD13,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Laminin,
http://linkedlifedata.com/resource/pubmed/chemical/Proteoglycans,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/matrigel
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1180-91
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14871998-Adenocarcinoma, Clear Cell,
pubmed-meshheading:14871998-Adenocarcinoma, Mucinous,
pubmed-meshheading:14871998-Aminopeptidases,
pubmed-meshheading:14871998-Animals,
pubmed-meshheading:14871998-Antigens, CD13,
pubmed-meshheading:14871998-Apoptosis,
pubmed-meshheading:14871998-Cell Adhesion,
pubmed-meshheading:14871998-Cell Division,
pubmed-meshheading:14871998-Cell Line, Tumor,
pubmed-meshheading:14871998-Cell Membrane,
pubmed-meshheading:14871998-Cisplatin,
pubmed-meshheading:14871998-Collagen,
pubmed-meshheading:14871998-Cystadenocarcinoma, Serous,
pubmed-meshheading:14871998-Dose-Response Relationship, Drug,
pubmed-meshheading:14871998-Drug Combinations,
pubmed-meshheading:14871998-Female,
pubmed-meshheading:14871998-Humans,
pubmed-meshheading:14871998-Immunohistochemistry,
pubmed-meshheading:14871998-Laminin,
pubmed-meshheading:14871998-Mice,
pubmed-meshheading:14871998-Mice, Nude,
pubmed-meshheading:14871998-Neoplasm Transplantation,
pubmed-meshheading:14871998-Ovarian Neoplasms,
pubmed-meshheading:14871998-Plasmids,
pubmed-meshheading:14871998-Proteoglycans,
pubmed-meshheading:14871998-RNA, Messenger,
pubmed-meshheading:14871998-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:14871998-S Phase,
pubmed-meshheading:14871998-Time Factors,
pubmed-meshheading:14871998-Transfection
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts.
|
|
pubmed:affiliation |
Department of Medical Oncology, Vrÿe Universiteit Medical Center, 1007 MB Amsterdam, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
